|
Filipina Breast Cancer Support: Which Model is Meaningful? [2] |
Nancy Burke, PhD |
Cancer/Oncology |
|
|
|
Communicating about Clinical Trials: Bringing the Cancer Information Service (CIS) to the Underserved [II] |
Nancy Burke, PhD |
Cancer/Oncology, Patient and Peer Education |
|
|
|
Buong Puso: Linking Filipinas with Breast Cancer to Care and Support Resources |
Nancy Burke, PhD |
Cancer/Oncology |
|
|
|
Sinag Tala (Bright Star): Pilipina Breast Cancer Support Group Outreach |
Nancy Burke, PhD |
Cancer/Oncology |
|
|
|
Filipina Breast Cancer Support: What Model is Meaningful? [1] |
Nancy Burke, PhD |
Cancer/Oncology |
|
|
|
Communicating about Clinical Trials: Bringing the Cancer Information Service (CIS) to the Underserved [I] |
Nancy Burke, PhD |
Cancer/Oncology |
|
|
|
Sustainable approaches to care delivery in Uganda |
Gabriel Chamie, MD |
HIV/AIDS, Cancer/Oncology, Cardiovascular Disease, Chronic Respiratory Disease, Diet, Exercise, and Obesity, Implementation and Behavioral Science, Engagement in Care, Treatment Adherence |
|
|
|
To Discover and Characterize Novel Viruses in Cancer |
Charles Chiu, MD, PhD |
Infectious Disease, Cancer/Oncology |
|
|
|
Tissue Biopsy Samples from Head and Neck Cancers |
Charles Chiu, MD, PhD |
Cancer/Oncology, Drug and Diagnostics Development |
|
|
|
FACES Patient Care fund for research at Kenya |
Craig Cohen, MD, MPH |
HIV/AIDS, Infectious Disease, Sexually Transmitted Infections (STIs), Cancer/Oncology, Diet, Exercise, and Obesity, Women's Health, Labor and Delivery, Family Planning, Pediatrics, Newborn and Infant Health, Adolescent Health, Health Economics and Effectiveness, Access or Barriers to Care, Stigma and Discrimination, Training and Capacity Building, Training International Scholars and Clinicians |
|
|
|
University of California Global Health Institute Program for Fellows and Scholars |
Craig Cohen, MD, MPH |
Sexually Transmitted Infections (STIs), Zoonosis, Emerging Disease, and Drug Resistance, Neglected Tropical Diseases (NTDs), HIV/AIDS, Opportunistic Infection, Tuberculosis, Malaria, Noncommunicable and/or Chronic Disease, Surgery and Anesthesia, Cancer/Oncology, Cardiovascular Disease, Chronic Respiratory Disease, Diabetes, Occupational and Environmental Disease, Diet, Exercise, and Obesity, Malnutrition, Micronutrients, Food Insecurity, Eye Disease and Blindness, Oral Health, Drug and Diagnostics Development, Immunology, Genetics, Pharmacology and Drug Treatment, Neurology and Mental Health, Dementia and Cognitive Impairment, Trauma and PTSD, Women's Health, Aging, Labor and Delivery, Family Planning, Pediatrics, Newborn and Infant Health, Adolescent Health, Health Economics and Effectiveness, Access or Barriers to Care, Immigration and Migration, Stigma and Discrimination, Smoking and Tobacco, Policy and Standards of Care, Systematic Reviews and Guideline Development, Epidemiology and Surveillance, Triangulation, Global Strategic Information, Implementation and Behavioral Science, Engagement in Care, Substance Abuse, Treatment Adherence, Health Systems Strengthening, Risk Reduction and Prevention, Residencies, Fellowships, and Postdoctoral Training |
|
|
|
East Africa IEDEA Regional Consortium |
Craig Cohen, MD, MPH |
HIV/AIDS, Tuberculosis, Cancer/Oncology, Epidemiology and Surveillance |
|
|
|
University of California Global Health Institute Program for Fellows and Scholars |
Craig Cohen, MD, MPH |
Infectious Disease, HIV/AIDS, Tuberculosis, Malaria, Surgery and Anesthesia, Cancer/Oncology, Chronic Respiratory Disease, Diabetes, Occupational and Environmental Disease, Eye Disease and Blindness, Oral Health, Dementia and Cognitive Impairment, Trauma and PTSD, Women's Health, Pediatrics, Policy and Standards of Care, Epidemiology and Surveillance |
|
|
|
Stigma as a barrier to cancer palliative care outcomes among people with HIV in India |
Maria Ekstrand, PhD |
Cancer/Oncology, Stigma and Discrimination |
|
|
|
Herpesviral Gene Expression in Kaposi's Sarcoma |
|
HIV/AIDS, Cancer/Oncology, Genetics |
|
|
|
Development of Transporter Targeted Platinum Drugs for Neuroblastoma |
|
Cancer/Oncology, Neurology and Mental Health |
|
|
|
Development of Targeted Anti-Cancer Platinum Analogs |
|
Cancer/Oncology, Drug and Diagnostics Development |
|
|
|
Postdoctoral training in tobacco control |
Stanton Glantz, PhD |
Cancer/Oncology, Smoking and Tobacco, Residencies, Fellowships, and Postdoctoral Training |
|
|
|
Evaluating a community-driven cervical cancer prevention model in western Kenya |
Megan Huchko, MD |
HIV/AIDS, Cancer/Oncology, Women's Health |
|
|
|
Cervical Cancer Screening with a Novel Biomarker in HIV-Infected Women |
Megan Huchko, MD |
HIV/AIDS, Cancer/Oncology |
|
|
|
Cardiovascular, Pulmonary & Hematological Disease in HIV: Prevention & Treatment |
Peter Hunt, MD |
HIV/AIDS, Cancer/Oncology, Cardiovascular Disease, Aging |
|
|
|
AIDS Malignancies Consortium |
Lawrence Kaplan, MD |
HIV/AIDS, Cancer/Oncology |
|
|
|
AIDS Malignancy Consortium (AMC) |
Lawrence Kaplan, MD |
HIV/AIDS, Opportunistic Infection, Cancer/Oncology |
|
|
|
DAIDS A5298 Study: A Randomized, Double-Blinded, Placebo-Controlled, Phase III Trial of the Quadrivalent HPV Vaccine to Prevent Anal Human Papillomavirus Infection in HIV-Infected Men |
Anne Luetkemeyer, MD |
HIV/AIDS, Cancer/Oncology |
|
|
|
Antiretroviral Therapy of AIDS-Related Kaposi's Sarcoma in Africa |
Jeffrey Martin, MD, MPH |
HIV/AIDS, Cancer/Oncology |
|
|
|
Abbott Drug Donation for Antiretroviral Therapy of AIDS-Related Kaposi's Sarcoma in Africa |
Jeffrey Martin, MD, MPH |
HIV/AIDS, Cancer/Oncology |
|
|
|
Early Stage Diagnosis of Kaposi's Sarcoma in Limited Resource Settings using KS-Detect |
Jeffrey Martin, MD, MPH |
HIV/AIDS, Cancer/Oncology, Drug and Diagnostics Development |
|
|
|
Uganda-UCSF Research Training Program in HIV-Associated Malignancies |
Jeffrey Martin, MD, MPH |
HIV/AIDS, Cancer/Oncology |
|
|
|
Merck Drug Donation for Antiretroviral Therapy of AIDS-Related Kaposi Sarcoma in Africa |
Jeffrey Martin, MD, MPH |
HIV/AIDS, Cancer/Oncology |
|
|
|
NAAccord (CHK-UP on HIV Supplement) |
Jeffrey Martin, MD, MPH |
HIV/AIDS, Noncommunicable and/or Chronic Disease, Cancer/Oncology, Cardiovascular Disease |
|
|
|
Immunoprotective Effects of Lopinavir/Ritonavir in HIV-Infected Patients in Sub-Saharan Africa |
Jeffrey Martin, MD, MPH |
HIV/AIDS, Cancer/Oncology |
|
|
|
Uganda-UCSF Consortium on Prevention and Early Detection of HIV-associated Cancer |
Jeffrey Martin, MD, MPH |
HIV/AIDS, Opportunistic Infection, Cancer/Oncology |
|
|
|
Early Stage Diagnosis of Kaposi's Sarcoma in Limited Resource Settings using KS-Detect |
Jeffrey Martin, MD, MPH |
HIV/AIDS, Cancer/Oncology, Drug and Diagnostics Development |
|
|
|
Immunosenescence Profiles of Atypical Cases of Kaposi Sarcoma in Well-Controlled HIV Infection |
Toby Maurer, MD |
HIV/AIDS, Cancer/Oncology |
|
|
|
Effects of Maraviroc on HIV-related Kaposi Sarcoma |
Toby Maurer, MD |
HIV/AIDS, Cancer/Oncology |
|
|
|
The Role of PD-1 Pathway and Tissue Microenvironment in HIV-Kaposi Sarcoma and Endemic Kaposi Sarcoma Cohort in Western Kenya |
Toby Maurer, MD |
HIV/AIDS, Cancer/Oncology |
|
|
|
Evaluation of technetium Tc 99m tilmanocept (Lymphoseek) Localization, Retention, and Distribution in Primary Cutaneous Kaposi's Sarcoma (KS) and Lymphatic Drainage from KS Lesions by SPECT and SPECT/CT Imaging |
Toby Maurer, MD |
HIV/AIDS, Cancer/Oncology, Pharmacology and Drug Treatment |
|
|
|
Randomized Trial to Increase Adherence to Cervical Cancer Screening Guidelines for Young Women |
Anna-Barbara Moscicki, MD |
Cancer/Oncology, Women's Health |
|
|
|
Thai Red Cross S&S, HPV TA008 |
Joel Palefsky, MD |
Infectious Disease, Sexually Transmitted Infections (STIs), Cancer/Oncology, Pharmacology and Drug Treatment |
|
|
|
Thai Red Cross S&S, HN177 |
Joel Palefsky, MD |
Infectious Disease, Sexually Transmitted Infections (STIs), Cancer/Oncology |
|
|
|
Cidofovir for Perianal Dysplasia in HIV Patients |
Joel Palefsky, MD |
HIV/AIDS, Cancer/Oncology |
|
|
|
ANCHOR (Anal Cancer/HSIL Outcomes Research) Study (AMC Supplement Administrative Core) |
Joel Palefsky, MD |
Cancer/Oncology |
|
|
|
A Phase I, Dose Escalation Study To Establish Safety of Leukocyte Interleukin, Injection [Multikine] for Treatment of Perianal Condylomata In Adult Men and Women Who Are HIV/HPV Co-infected |
Joel Palefsky, MD |
HIV/AIDS, Opportunistic Infection, Cancer/Oncology |
|
|
|
Doris Duke Charitable Foundation International Clinical Research Fellowship Program |
Joel Palefsky, MD |
HIV/AIDS, Tuberculosis, Malaria, Cancer/Oncology, Cardiovascular Disease, Oral Health, Neurology and Mental Health, Women's Health, Pediatrics, Newborn and Infant Health, Immigration and Migration, Training and Capacity Building, Residencies, Fellowships, and Postdoctoral Training |
|
|
|
Determinants of Participation in an Anal Cancer Prevention Trial |
Joel Palefsky, MD |
Cancer/Oncology |
|
|
|
(PQ4) Anal HPV infection and anal HSIL among HIV-infected MSM aged 50+ years |
Joel Palefsky, MD |
Infectious Disease, HIV/AIDS, Cancer/Oncology |
|
|
|
A Master Agreement: HPV Testing of Samples from the AIDS Malignancy Consortium |
Joel Palefsky, MD |
HIV/AIDS, Cancer/Oncology, Women's Health |
|
|
|
HPV-Related Neoplasia among HIV-Seropositive Indian Men Who Have Sex With Men |
Joel Palefsky, MD |
HIV/AIDS, Cancer/Oncology |
|
|
|
(PQ5) Role of HIV-associated cellular miRNAs in HPV 16-induced pathogenesis |
Joel Palefsky, MD |
Infectious Disease, Sexually Transmitted Infections (STIs), Cancer/Oncology |
|
|
|
The Microbiome and Anal Cancer Pathogenesis in HIV-infected Men who have Sex with Men |
Joel Palefsky, MD |
Infectious Disease, HIV/AIDS, Cancer/Oncology |
|
|
|
Anal Cytology/HPV Testing Study |
Joel Palefsky, MD |
Infectious Disease, Cancer/Oncology, Systematic Reviews and Guideline Development |
|
|
|
HPV testing of samples from the AIDS Malignancy Consortium |
Joel Palefsky, MD |
HIV/AIDS, Opportunistic Infection, Cancer/Oncology |
|
|
|
HPV Cervical Neoplasia in a Long-Term HIV+ Cohort |
Joel Palefsky, MD |
Sexually Transmitted Infections (STIs), Cancer/Oncology, Women's Health |
|
|
|
Administrative Supplements to Cancer Centers Support Grants to Stimulate Collaborative HIV Malignancy Research in Low and Middle Income Countries |
Joel Palefsky, MD |
HIV/AIDS, Cancer/Oncology, Women's Health |
|
|
|
Anal Human Papillomavirus (HPV) in Methamphetamine (MA) Using and Non-Using Men Who Have Sex with Men (MSM) in Los Angeles |
Joel Palefsky, MD |
Infectious Disease, Cancer/Oncology, Substance Abuse, Risk Reduction and Prevention |
|
|
|
SMART Anal Dysplasia Sub-Study |
Joel Palefsky, MD |
HIV/AIDS, Opportunistic Infection, Cancer/Oncology |
|
|
|
Epidemiologic Effects of ART on HIV-related Anal Cancer and Anal Dysplasia |
Joel Palefsky, MD |
Infectious Disease, HIV/AIDS, Cancer/Oncology |
|
|
|
HIV/HPV cancer prevention treatment and pathogenesis: Rwanda /Einstein Consortium |
Joel Palefsky, MD |
HIV/AIDS, Opportunistic Infection, Cancer/Oncology |
|
|
|
Anal Dysplasia SCC Supplement for P30 Cancer Support Grant to Stimulate HIV/AIDS Cancer Research Projects NCI-designated Cancer Centers |
Joel Palefsky, MD |
HIV/AIDS, Infectious Disease, Cancer/Oncology |
|
|
|
GINI: Gardasil Immunogenicity with Needle-free Injection-Safety and Immunogenicity of Gardasil using IM and ID needle-free injection delivery |
Joel Palefsky, MD |
Sexually Transmitted Infections (STIs), Cancer/Oncology |
|
|
|
California Division Special Research Scholar Grant in HIV-Related Cancers |
Joel Palefsky, MD |
HIV/AIDS, Cancer/Oncology |
|
|
|
HPV and AIDS Malignancies Clinical Trials Consortium (AMC) |
Joel Palefsky, MD |
HIV/AIDS, Cancer/Oncology |
|
|
|
Women and Infants Transmission Study - Human Papillomavirus Protocol |
Joel Palefsky, MD |
Infectious Disease, HIV/AIDS, Cancer/Oncology, Women's Health |
|
|
|
Next Generation of HPV and Cervical Cancer Research in HIV+ Women |
Joel Palefsky, MD |
HIV/AIDS, Infectious Disease, Sexually Transmitted Infections (STIs), Cancer/Oncology |
|
|
|
Redes En Acción: National Latino Cancer Research Network |
Eliseo Perez-Stable, MD |
Cancer/Oncology |
|
|
|
Redes En Accion: National Latino Cancer Research Network |
Eliseo Perez-Stable, MD |
Cancer/Oncology, Immigration and Migration, Engagement in Care |
|
|
|
Promotoras for Cancer Survivorship-Redes/LAF |
Eliseo Perez-Stable, MD |
Cancer/Oncology, Women's Health |
|
|
|
Promotoras for Cancer Survivorship-Redes/LAF |
Eliseo Perez-Stable, MD |
Cancer/Oncology |
|
|
|
Precision Targeting of Castration Resistant Prostate Cancer with a Novel Ferrous Iron-Dependent Therapeutic Delivery and Tumor Imaging Strategy |
Adam Renslo, PhD |
Cancer/Oncology, Immunology |
|
|
|
Using Comparative Effectiveness Analyses to Optimize Cervical Cancer Screening |
|
Cancer/Oncology |
|
|
|
Kaiser Permanente Cervical Cancer Prevention (CCaP) Network |
|
Cancer/Oncology, Women's Health |
|
|
|
6th International Workshop on Breast Cancer Risk Assessment |
|
Cancer/Oncology, Women's Health |
|
|
|
Obesity, Body Fat Distribution and Cancer Risk in the Multiethnic Cohort (Core C) |
|
Cancer/Oncology, Diet, Exercise, and Obesity |
|
|
|
Lesion Composition and Quantitative Imaging Analysis on Breast Cancer Diagnosis |
|
Noncommunicable and/or Chronic Disease, Cancer/Oncology, Risk Reduction and Prevention |
|
|
|
Subregional Breast Density and Cancer Risk |
|
Cancer/Oncology |
|
|
|
Noninvasive Identifiers of Women with High Breast Density |
|
Cancer/Oncology, Women's Health |
|
|
|
The Cancer Genome Atlas (TCGA) Pilot Program |
|
Cancer/Oncology, Systematic Reviews and Guideline Development |
|
|
|
International Clinical Research Fellowship |
Christopher Stewart, MD |
Zoonosis, Emerging Disease, and Drug Resistance, HIV/AIDS, Tuberculosis, Malaria, Cancer/Oncology, Cardiovascular Disease, Chronic Respiratory Disease, Diabetes, Occupational and Environmental Disease, Eye Disease and Blindness, Oral Health, Residencies, Fellowships, and Postdoctoral Training |
|
|
|
HIV and HPV Transmission Across Mucosal Epithelia |
Sharof Tugizov, PhD |
HIV/AIDS, Cancer/Oncology |
|
|
|
Microtubule Complexes Involved in Intracellular Transport |
Ronald Vale, PhD |
Cancer/Oncology |
|
|
|
UCSF-GIVI Center for AIDS Research (CFAR) |
Paul Volberding, MD |
HIV/AIDS, Tuberculosis, Malaria, Cancer/Oncology, Cardiovascular Disease, Drug and Diagnostics Development, Immunology, Pharmacology and Drug Treatment, Neurology and Mental Health, Trauma and PTSD, Women's Health, Pediatrics, Implementation and Behavioral Science, Training and Capacity Building, Training International Scholars and Clinicians |
|
|
|
Personal Patient Profile - Prostate (P3P): A Randomized Multi-site Trial |
Leslie Wilson, PhD, MS |
Cancer/Oncology |
|
|
|
Partnership to Advance Breast Cancer Research |
Tracey Woodruff, PhD, MPH |
Cancer/Oncology, Women's Health |
|
|
|
Partnership to Advance Breast Cancer Research |
Tracey Woodruff, PhD, MPH |
Cancer/Oncology, Occupational and Environmental Disease, Women's Health |
|
|
|
A Workshop on Applications of Mechanistic Information in Human Health Risk Assessment |
Tracey Woodruff, PhD, MPH |
Cancer/Oncology, Occupational and Environmental Disease |
|
|
|
Functional Studies on Genetic Variants of PTPN14 |
|
Cancer/Oncology |
|
|
|
Center for Interdisciplinary Research on Childhood Leukemia and the Environment |
John Balmes, MD |
Cancer/Oncology, Occupational and Environmental Disease, Pediatrics |
|
|
|
Spirit of Eagles Communities Network Program |
Neal Benowitz, MD |
Cancer/Oncology |
|
|
|
A Pilot Study of FOLFOX in Combination with Bevacizumab in Patients with Advanced Neuroendocrine Tumors |
|
Cancer/Oncology, Pharmacology and Drug Treatment |
|
|
|
Real-World Treatment Patterns and Associated Outcomes Among Patients with Advanced Progressive Pancreatic Neuroendocrine Tumors |
|
Cancer/Oncology |
|
|
|
The Breast and Cervical Cancer Care Coordination and Navigation Program |
Claire Brindis, DrPH |
Cancer/Oncology, Women's Health |
|
|
|
DLM-10-001: An Open-Label, Single Arm, Safety and Tolerability Dose-escalation Study of DAG in Patients with Recurrent Malignant Glioma or Progressive Secondary Brain Tumor |
|
Cancer/Oncology |
|
|
|
Evaluation of Pao Pereira, a natural product of the extract of rainforest tree, in malignant brain tumor cell lines |
|
Cancer/Oncology, Drug and Diagnostics Development |
|
|
|
Phase II Study of 7 Days On/7 Days Off Temozolomide in Patients with High Grade Glioma |
|
Cancer/Oncology, Pharmacology and Drug Treatment |
|
|
|
A Phase I Study of Convection-Enhanced, Image-Assisted Delivery of Liposomal-Irinotecan Using Imaging in High Grade Glioma |
|
Cancer/Oncology |
|
|
|
JBAL: A Phase 2 Study of LY2157299 Monohydrate Monotherapy or LY2157299 Monohydrate plus Lomustine Therapy compared to Lomustine Monotherapy in Patients with Recurrent Glioblastoma |
|
Cancer/Oncology, Pharmacology and Drug Treatment |
|
|
|
Taste for the Cure and a Taste of Science |
|
Cancer/Oncology, Women's Health |
|
|
|
Athena Breast Care Network |
|
Cancer/Oncology, Women's Health |
|
|
|
Establishment of a Philippine Cancer Phenome-Biobanking System |
Linda Giudice, MD, PhD, MSc |
Cancer/Oncology |
|
|
|
Quality of Mammography Facilities Serving Vulnerable Women |
|
Cancer/Oncology, Women's Health |
|
|
|
UCSF-Kaiser Building Interdisciplinary Research Careers in Women's Health Program |
Ruth Greenblatt, MD |
HIV/AIDS, Noncommunicable and/or Chronic Disease, Cancer/Oncology, Cardiovascular Disease, Diet, Exercise, and Obesity, Dementia and Cognitive Impairment, Women's Health, UCSF Professional Education |
|
|
|
Molecular Methods for Cervical Cancer Screening in HIV+ Women |
Nancy Hessol, MSPH |
Cancer/Oncology, Drug and Diagnostics Development, Women's Health |
|
|
|
Antiretroviral Therapy Strategies to Lower Cancer Risk in HIV-Infected Persons |
Nancy Hessol, MSPH |
HIV/AIDS, Cancer/Oncology |
|
|
|
Leveraging the California Cancer Registry to Measure and Improve the Quality of Cancer Care |
Robert Hiatt, MD, PhD |
Cancer/Oncology, Health Economics and Effectiveness, Epidemiology and Surveillance |
|
|
|
New Paradigm of Breast Cancer Causation & Prevention |
Robert Hiatt, MD, PhD |
Cancer/Oncology, Women's Health |
|
|
|
New Paradigm of Breat Cancer Causation and Prevention - Phase II |
Robert Hiatt, MD, PhD |
Cancer/Oncology, Occupational and Environmental Disease, Women's Health |
|
|
|
New Paradigm of Breast Cancer Causation and Prevention |
Robert Hiatt, MD, PhD |
Cancer/Oncology, Occupational and Environmental Disease |
|
|
|
New Paradigm of Breast Cancer Causation and Prevention |
Robert Hiatt, MD, PhD |
Cancer/Oncology, Women's Health |
|
|
|
Breast Cancer and the Environment Research Program Coordinating Center |
Robert Hiatt, MD, PhD |
Cancer/Oncology |
|
|
|
Bay Area Breast Cancer and Environment Research Center |
Robert Hiatt, MD, PhD |
Cancer/Oncology, Women's Health |
|
|
|
Structuring population health sciences within a faculty of health sciences in East Africa |
Robert Hiatt, MD, PhD |
Cancer/Oncology, Health Systems Strengthening, Training and Capacity Building |
|
|
|
Evaluating a Community-Driven Cervical Cancer Prevention program in Western Kenya |
Robert Hiatt, MD, PhD |
Cancer/Oncology |
|
|
|
Bay Area Breast Cancer and the Environment Research Center |
Robert Hiatt, MD, PhD |
Cancer/Oncology, Occupational and Environmental Disease |
|
|
|
HPV-Specific T Cell Responses and Anogenital HPV Disease in Women of the WIHS |
|
HIV/AIDS, Cancer/Oncology, Women's Health |
|
|
|
Breast Cancer Risk Reduction: A Patient-Doctor Intervention |
Celia Kaplan, DrPH |
Cancer/Oncology, Women's Health |
|
|
|
Lung Cancer Screening: Development of a Clinic-Based Intervention |
Celia Kaplan, DrPH |
Cancer/Oncology |
|
|
|
Mechanisms of Bartonella Virulence in AIDS Patients |
|
HIV/AIDS, Cancer/Oncology, Risk Reduction and Prevention |
|
|
|
Pathogenesis of HIV-Related Bacillary Angiomatosis |
|
HIV/AIDS, Opportunistic Infection, Infectious Disease, Cancer/Oncology |
|
|
|
Decision-Making about CAM Across the Cancer Continuum: An Observational Study |
|
Cancer/Oncology |
|
|
|
Genetic Analysis of the Nucleosome and RNA Polymerase II: a Systems Approach |
Nevan Krogan, PhD, MSc |
Noncommunicable and/or Chronic Disease, Cancer/Oncology, Genetics |
|
|
|
Physical and Genetic Interaction Landscape of the Tyrosine Kinome |
Nevan Krogan, PhD, MSc |
Cancer/Oncology, Diabetes, Immunology |
|
|
|
Children's Oncology Group Acute Lymphoblastic Leukemia High Risk Molecular Markers |
|
Cancer/Oncology |
|
|
|
Testing Targeted Therapy in Philadelphia Chromosome-Like (Ph-Like) All |
|
Cancer/Oncology, Drug and Diagnostics Development |
|
|
|
PAAR4Kids-Pharmacogenomics Research Network |
|
Cancer/Oncology, Genetics, Pharmacology and Drug Treatment |
|
|
|
Improving outcomes for JMML (juvenile myelomonocytic leukaemia) through targeted therapeutics |
|
Cancer/Oncology, Pediatrics |
|
|
|
Environmental and Molecular Epidemiology of Childhood Leukemia |
|
Cancer/Oncology, Pediatrics |
|
|
|
Modeling Juvenile Myelomonocytic Leukemia with Patient-Derived Induced Pluripotent Stem Cells |
|
Cancer/Oncology, Adolescent Health |
|
|
|
Sanofi-Aventis SAR650894 Program - Research Component |
|
Cancer/Oncology, Drug and Diagnostics Development |
|
|
|
131I-MIBG Imaging and Therapy for Neuroblastoma: Infrastructure Proposal |
|
Cancer/Oncology |
|
|
|
Alex's Lemonade Stand Foundation Post Program |
|
Cancer/Oncology, Pediatrics |
|
|
|
New Approaches to Neuroblastoma Therapy (NANT) |
|
Cancer/Oncology, Neurology and Mental Health |
|
|
|
Prostate Cancer and Pesticides |
|
Cancer/Oncology, Occupational and Environmental Disease |
|
|
|
A Phase Ib Dose Escalation/Randomized Phase II, Multicenter, Open-label Study of BYL719 in Combination With Cetuximab in Patients With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma |
|
Cancer/Oncology |
|
|
|
Phase 1 Open-Label First-in-Human Dose-Escalating Safety and Tolerability Study Evaluating Subcutaneous Administration of Andes-1537 for Injection in Patients With Advanced Unresectable Malignancies That Are Refractory to All Standard |
|
Cancer/Oncology, Pharmacology and Drug Treatment |
|
|
|
Phase 1b, Open-Label, Dose-Escalation Study of the Safety and Pharmacology of MEGF0444A, A Humanized 1gG1 Antibody in Combination with Bevacizumab with or without Paclitaxel in Patients with Locally Advanced or Metastatic Solid Tumors |
|
Cancer/Oncology, Pharmacology and Drug Treatment |
|
|
|
Phase I Parallel Protocol of MK-8669 (Ridaforolimus) + MK-2206 and MK-8669 (Ridaforolimus) + MK-0752 Doublets (MKMK) in Patients with Advanced Cancer |
|
Cancer/Oncology |
|
|
|
A Phase 1B, Multi-Center, Open Label, Dose Escalation Study of Oral LDE225 in Combination with BKM120 in Patients with Advanced Solid Tumors |
|
Cancer/Oncology, Women's Health |
|
|
|
An Open-label, Multi-center, Extension Study of NKTR 102 in Subjects Previously Enrolled in NKTR-102 Studies |
|
Cancer/Oncology |
|
|
|
A Phase I Open-Label, Dose-Escalation Study of the Phosphoinositide 3-Kinase Inhibitor GSK2126458 in Subjects with Solid Tumors or Lymphoma |
|
Cancer/Oncology |
|
|
|
The role of HDAC2 in hormone therapy resistance |
|
Cancer/Oncology |
|
|
|
A Phase I Study to Assess the Bioequivalence of 2 Formulations of TKI258, FMI Capsule and FMI Tablet, in Patients with Advanced Solid Tumors |
|
Cancer/Oncology |
|
|
|
Signalling thresholds and negative B-cell selection in acute lymphoblastic leukaemia |
|
Cancer/Oncology, Pediatrics |
|
|
|
Pre-B Cell Receptor Signaling in Acute Lymphoblastic Leukemia |
|
Cancer/Oncology |
|
|
|
AID-Mediated Genetic Instability in Bcr-Abl1-Transformed B Cell Lineage Leukemia |
|
Cancer/Oncology |
|
|
|
Negative Feedback and oncogene signaling in leukemia |
|
Cancer/Oncology |
|
|
|
Infectious Origins of Childhood Leukemia [II] |
|
Cancer/Oncology |
|
|
|
Negative feedback signaling in tyrosine kinase-driven leukemia |
|
Cancer/Oncology |
|
|
|
Pharmacological hyperactivation of Ras-MAPK signaling to target Ph+ ALL |
|
Cancer/Oncology, Pediatrics |
|
|
|
Targeting BCL6 in tyrosine kinase-driven leukemia |
|
Cancer/Oncology |
|
|
|
Psychosocial Support Services for Latinas with Breast Cancer |
|
Cancer/Oncology, Neurology and Mental Health, Women's Health |
|
|
|
Translating a Stress Management Program for Latinas |
|
Cancer/Oncology, Women's Health, Access or Barriers to Care |
|
|
|
Nuevo Amanecer: Promoting the Psychosocial Health of Latinas |
|
Cancer/Oncology, Neurology and Mental Health, Women's Health |
|
|
|
Promoting Post-Treatment Self-Management among Latinos with Cancer |
|
Cancer/Oncology, Access or Barriers to Care, Immigration and Migration, Stigma and Discrimination |
|
|
|
Meeting the self-care needs of Latinas after Breast Cancer |
|
Cancer/Oncology, Women's Health, Access or Barriers to Care, Immigration and Migration |
|
|
|
Nuevo Amanecer: Promoting the Psychosocial Health of Latinas |
|
Cancer/Oncology, Women's Health |
|
|
|
The Patient Cancer OUtreach, Navigation, Technology and Support (COUNTS) Project: Addressing Care for Asian Americans with Cancer |
Tung Nguyen, MD |
Cancer/Oncology |
|
|
|
Lay health workers and colorectal cancer screening among Chinese Americans |
Tung Nguyen, MD |
Cancer/Oncology, Patient and Peer Education |
|
|
|
Reducing Disparities in Colorectal Cancer Screening in Vietnamese Americans |
Tung Nguyen, MD |
Cancer/Oncology |
|
|
|
Biochemistry and Hepatic Toxicity of Carbon Radicals |
|
Cancer/Oncology |
|
|
|
Hemoprotein Oxidation and Heme Catabolism |
|
Cancer/Oncology |
|
|
|
Colorectal Cancer Screening with FIT during Annual Flu Shot Clinics |
Michael Potter, MD |
Cancer/Oncology, Engagement in Care, Patient and Peer Education |
|
|
|
Beacon (Breast Cancer Outcomes with Nktr-102): a Phase 3 Study of Nktr-102 Versus Treatment of Physician's Choice in Patients with Locally Recurrent or Metastatic Breast Cancer Previously Treated With Anthracycline, Taxane and Capecitabine |
|
Cancer/Oncology, Women's Health |
|
|
|
Enhancing the Efficacy of Chemotherapy in Triple Negative/Basal-like Breast Cancer by Targeting Macrophages |
|
Cancer/Oncology |
|
|
|
Open-Label, Expanded Access Protocol of BSI-201 in Combination with Gemcitabine/Carboplatin in Patients with ER-, PR-, and HER2-Negative Metastatic Breast Cancer |
|
Cancer/Oncology, Women's Health |
|
|
|
A Single Arm, Open-Label, Phase 2 Study of MGAH22 (Fc-Optimized Chimeric Anti-HER2 Monoclonal Antibody) in Patients with Relapsed or Refractory Advanced Breast Cancer Whose Tumors Express HER2 at the 2+ Level by Immunohistochemistry and Lack Evidence |
|
Cancer/Oncology |
|
|
|
Master Member Agreement: Translational Breast Cancer Research Consortium |
|
Cancer/Oncology, Epidemiology and Surveillance |
|
|
|
Phase 1 Study of IMC-CS4, a Monoclonal Antibody Targeted to the CSF-1 Receptor (CSF-1R), in Subjects With Advanced Solid Tumors Refractory to Standard Therapy or for Which No Standard Therapy is Available |
|
Cancer/Oncology |
|
|
|
The Breast Cancer Clinical Trials Consortium |
|
Cancer/Oncology, Women's Health |
|
|
|
BEACON Study (BrEAst Cancer Outcomes with NKTR-102): Phase 3 Study of NKTR-102 versus Treatment of Physician's Choice (TPC) in Patients with Locally Recurrent or Metastatic Breast Cancer Previously Treated with Anthracycline, a Taxane and Capecitabine |
|
Cancer/Oncology, Pharmacology and Drug Treatment, Women's Health |
|
|
|
Phase III Study Evaluating Palbociclib (PD-0332991), a Cycline-Dependent Kinase (CDK) 4/6 Inhibitor in Patients with Hormone-Receptor-Positive, HER2-Normal Primary Breast Cancer with High Relapse Risk after Neoadjuvant Chemotherapy "Penelope" |
|
Cancer/Oncology, Women's Health |
|
|
|
Cellular mechanisms of resistance to chemotherapy and the impact of immune modulating therapy, and molecular characterization of circulating tumor cells (CTCs) in patients with advanced breast cancer (ABC) |
|
Cancer/Oncology, Women's Health |
|
|
|
Phase IA, Multicenter, Open-label Dose Escalation Study of Oral BYL719, in Adult Patients With Advanced Solid Malignancies, Whose Tumors Have an Alteration of the PIK3CA Gene |
|
Cancer/Oncology |
|
|
|
A Phase II, Single Arm Study of the Use of Steroid-Based Mouthwash to Prevent Stomatitis in Postmenopausal Women with Advanced or Metastatic Hormone Receptor Positive Breast Cancer Being Treated with Everolimus plus Exemestane. |
|
Cancer/Oncology, Women's Health |
|
|
|
A Phase I/II Study Evaluating Microwave Hyperthermia and Thermodox (Lyso-Thermosensitive Liposomal Doxorubicin) in Patients with Breast Cancer Recurrence at the Chest Wall (DIGNITY) |
|
Cancer/Oncology, Women's Health |
|
|
|
Protocol GS-US-334-0139 An Expanded Access Phase 2 Study of Sofosbuvir and Ribavarin with or without Pegylated Interferon for 24 Weeks in Subjects Who Have Undergone Liver Transplantation and Who Have Aggressive Recurrent Hepatitis C Infection |
|
Infectious Disease, Cancer/Oncology |
|
|
|
Reducing Breast Cancer Risk in Korean American Women |
Janice Tsoh, PhD |
Cancer/Oncology, Genetics, Immigration and Migration |
|
|
|
Palliative wound care training in a cancer referral hospital in Dar es Salaam, Tanzania |
Kimberly Baltzell, RN, PhD, MS |
Cancer/Oncology, Training International Scholars and Clinicians |
|
|
|
Viruses in Breast Fluid: Biomarkers for Breast Cancer? |
Kimberly Baltzell, RN, PhD, MS |
Cancer/Oncology, Drug and Diagnostics Development, Women's Health |
|
|
|
Oncogenic Viral Biomarkers in Nonmalignant Human Breast Tissue |
Kimberly Baltzell, RN, PhD, MS |
Cancer/Oncology, Drug and Diagnostics Development, Women's Health |
|
|
|
Exploring Early Detection Methods: Using the Intraductal Approach to Predict Breast Cancer |
Kimberly Baltzell, RN, PhD, MS |
Cancer/Oncology, Women's Health |
|
|
|
Exploring the Role of CDK4 and CDK6 in Melanoma Maintenance |
|
Cancer/Oncology |
|
|
|
Exploring the Role of CDK4 and CDK6 in Melanoma Maintenance |
|
Cancer/Oncology |
|
|
|
Parsing Out The Role Of PI3'-Kinase Signaling In Lung Cancer Initiation, Progression And Therapy |
|
Cancer/Oncology |
|
|
|
Imaging Oncogene Activation and Tumor Development in Genetically Engineered Mice |
|
Cancer/Oncology |
|
|
|
Targeting Oncogenic BRAF And PI3'-Kinase Signaling For Melanoma Therapy |
|
Cancer/Oncology |
|
|
|
Regulation and Targets of the DNA Damage Checkpoint |
|
Cancer/Oncology |
|
|
|
Cellular and Genetic Origins of Astrocytes |
|
Noncommunicable and/or Chronic Disease, Cancer/Oncology, Neurology and Mental Health, Risk Reduction and Prevention |
|
|
|
Genome wide association study of breast cancer subtype and survival in Latinas |
Laura Fejerman, PhD |
Cancer/Oncology, Genetics, Epidemiology and Surveillance |
|
|
|
Identifying Human Breast Carcinogens Using Exposomics (2) |
Laura Fejerman, PhD |
Cancer/Oncology, Women's Health |
|
|
|
Exposomic approach to understand the effect of immigration and genetic ancestry on breast cancer risk in U.S. Latinas |
Laura Fejerman, PhD |
Cancer/Oncology, Occupational and Environmental Disease |
|
|
|
Admixture Mapping for Breast Cancer Subtypes Among African American Women |
Laura Fejerman, PhD |
Cancer/Oncology, Women's Health |
|
|
|
Latino Community Education Tool on Hereditary Breast Cancer |
Laura Fejerman, PhD |
Cancer/Oncology, Women's Health, Patient and Peer Education |
|
|
|
Biological implications of breast cancer protective variants in Latin American women with high Indigenous American ancestry |
Laura Fejerman, PhD |
Cancer/Oncology, Women's Health |
|
|
|
Planning for a Cancer Research Training Program in Tanzania |
Katherine Van Loon, MD, MPH |
Cancer/Oncology, Training International Scholars and Clinicians |
|
|
|
A Partnership for Training and Mentoring of Cancer Researchers in Tanzania |
Katherine Van Loon, MD, MPH |
Cancer/Oncology, Training and Capacity Building, Training International Scholars and Clinicians |
|
|
|
Patient Centered Videos to Enhance Informed Consent for Palliative Chemotherapy |
Katherine Van Loon, MD, MPH |
Cancer/Oncology |
|
|
|
Randomized, Double-Blind, Phase II Trial of Vitamin D Supplementation in Participants with Previously Untreated Metastatic Colorectal Cancer |
Katherine Van Loon, MD, MPH |
Cancer/Oncology, Drug and Diagnostics Development |
|
|
|
AgileMD Data Coordinator |
Katherine Van Loon, MD, MPH |
Cancer/Oncology, Policy and Standards of Care |
|
|
|
Dar es Salaam ESCC Case-Control Study |
Katherine Van Loon, MD, MPH |
Cancer/Oncology |
|
|
|
Impact of molecular phenotype on glioma metabolism and growth |
|
Cancer/Oncology |
|
|
|
MR Metabolic Imaging of Response to Targeted Therapies in GBM |
|
Cancer/Oncology, Drug and Diagnostics Development |
|
|
|
Metabolic Reprogramming in Brain Tumors |
|
Cancer/Oncology |
|
|
|
A Multicenter Phase I/II Trial of Abiraterone + BEZ235 in Metastatic, Castration-Resistant Prostate Cancer |
|
Cancer/Oncology |
|
|
|
The Prostate Cancer Clinical Trials Consortium: Clinical Research Site Application |
|
Cancer/Oncology |
|
|
|
A phase I/II, multicenter, open-label dose finding study of oral CFG920 in patients with metastatic castration-resistant prostate cancer |
|
Cancer/Oncology |
|
|
|
Serum Androgens as Predictors of Survival in Metastatic Prostate Cancer |
|
Cancer/Oncology |
|
|
|
A Randomized Phase 2 Study of Cabozantinib (XL184) in Combination with Abiraterone in Chemotherapy Naïve Subjects with Bone-Metastatic Castration-Resistant Prostate Cancer |
|
Cancer/Oncology |
|
|
|
An Open Label, Multicenter, Phase 2 Study to Determine the Safety and Efficacy of BIND-014 (Docetaxel Nanoparticles for Injectable Suspension), Administered to Patients With Metastatic Castration-Resistant Prostate Cancer |
|
Cancer/Oncology |
|
|
|
Training Program in Translational Brain Tumor Research |
|
Cancer/Oncology, Residencies, Fellowships, and Postdoctoral Training |
|
|
|
BRAF Mutation in Malignant Astrocytoma Origin, Evolution, and Response to Therapy |
|
Cancer/Oncology |
|
|
|
A Causal Role for Asymmetric Cell Division Defects in Glioma Initiation |
|
Noncommunicable and/or Chronic Disease, Cancer/Oncology |
|
|
|
Medical Scientist Training Program |
|
Noncommunicable and/or Chronic Disease, Cancer/Oncology, Dementia and Cognitive Impairment, Residencies, Fellowships, and Postdoctoral Training, UCSF Professional Education |
|
|
|
Fusion Genes As Therapeutic Targets in Malignant Pleural Mesothelioma |
|
Cancer/Oncology, Drug and Diagnostics Development |
|
|
|
Targeting the translational apparatus in MYCN-driven medulloblastoma |
|
Cancer/Oncology |
|
|
|
Murine Neuroblastoma Models for Preclinical Therapeutics |
|
Cancer/Oncology, Drug and Diagnostics Development |
|
|
|
MYCN, mTOR and translation control in medulloblastoma |
|
Cancer/Oncology, Pediatrics |
|
|
|
Genetic network analysis of cancer targets |
|
Cancer/Oncology |
|
|
|
Targeting BET-bromodomains in neuroblastoma |
|
Cancer/Oncology, Drug and Diagnostics Development, Pediatrics |
|
|
|
Cellular and Genetic Basis of Anaplastic Medulloblastoma |
|
Cancer/Oncology, Pediatrics |
|
|
|
(PQC4) Fate of cells disseminating from human breast cancer xenografts |
|
Cancer/Oncology, Risk Reduction and Prevention |
|
|
|
Environmental effects of the mammary gland across the lifespan |
|
Cancer/Oncology, Occupational and Environmental Disease, Women's Health |
|
|
|
Role of GATA3 in transcriptional pathways suppressing breast cancer metastasis |
|
Cancer/Oncology, Women's Health |
|
|
|
Transcriptional Regulation of Breast Cancer Metastasis |
|
Cancer/Oncology, Women's Health |
|
|
|
Role of Metalloproteinases in Mammary Gland Remodeling |
|
Cancer/Oncology |
|
|
|
Biomarkers for Environmental Exposures in Breast Cancer |
|
Cancer/Oncology, Women's Health |
|
|
|
Molecular and Cellular Mechanisms in Cancer |
|
Cancer/Oncology, Residencies, Fellowships, and Postdoctoral Training |
|
|
|
Molecular and Cellular Mechanisms in Cancer |
|
Cancer/Oncology, Residencies, Fellowships, and Postdoctoral Training |
|
|
|
Fundamental Mechanobiology of Tumor Progression |
|
Cancer/Oncology |
|
|
|
New ways of treating pancreatic cancer based on reversing K-Ras-mediated stemness |
|
Cancer/Oncology, Immunology |
|
|
|
Targeting KRAS Mutant Lung Cancers |
|
Cancer/Oncology |
|
|
|
Identifying neurofibromin-specific regulatory nodes for therapeutic targeting in NF1 |
|
Cancer/Oncology |
|
|
|
Fundamental Mechanobiology of Tumor Progression |
|
Cancer/Oncology |
|
|
|
Biomarkers that Predict the Response of AIDS-Related Kaposi's Sarcoma to Antiretroviral Therapy and the Risk of Developing Immune Reconstitution Inflammatory Syndrome |
|
HIV/AIDS, Cancer/Oncology |
|
|
|
Risk of Leukemia after Protracted Exposures to Low Doses of Ionizing Radiation. |
Lydia Zablotska, MD, MPA, PhD |
Noncommunicable and/or Chronic Disease, Cancer/Oncology, Genetics, Epidemiology and Surveillance, Risk Reduction and Prevention |
|
|
|
US and Canadian uranium processing cohorts: exposure, risk and relevance |
Lydia Zablotska, MD, MPA, PhD |
Cancer/Oncology, Occupational and Environmental Disease |
|
|
|
Canadian Fluoroscopy Cohort Study: Lifespan Mortality and Incidence Follow-Up |
Lydia Zablotska, MD, MPA, PhD |
Cancer/Oncology, Occupational and Environmental Disease |
|
|
|
Risk of hematologic cancers from repeated low-dose diagnostic radiation. |
Lydia Zablotska, MD, MPA, PhD |
Cancer/Oncology, Occupational and Environmental Disease |
|
|
|
Effects of the Chornobyl Accident on Thyroid Cancer and Leukemia & Related Diseases (NO1-CP-21178) |
Lydia Zablotska, MD, MPA, PhD |
Cancer/Oncology, Occupational and Environmental Disease |
|
|
|
Drugging the Switch-II Pocket of K-Ras |
Kevan Shokat, PhD |
Cancer/Oncology |
|
|
|
Affinity Isolation of Direct Kinase Substrates |
Kevan Shokat, PhD |
Cancer/Oncology |
|
|
|
Understanding the Interpersonal Context of HIV/HCV risk within Injecting Dyads |
Meghan Morris, PhD, MPH |
Infectious Disease, Sexually Transmitted Infections (STIs), HIV/AIDS, Cancer/Oncology |
|
|
|
A Study of Etiology of Esophageal Cancer in Tanzania (SEEC-Tanzania) |
|
Cancer/Oncology |
|
|
|
Recurrence of CIN2+ among HIV-infected women in Kisumu, Kenya two years after treatment with LEEP |
Keerthana Anand, MS |
HIV/AIDS, Cancer/Oncology, Women's Health |
|
|
|
A Multivariate Analysis of Risk Factors to Cervical HPV Infection: An Evaluation of 150 Women under the GINI Study in Bangkok, Thailand |
Sneh Patel, MS |
Infectious Disease, Cancer/Oncology, Pediatrics |
|
|
|
CAPTC - Institute for Human Virology - Nigeria (IHVN) Partner Testing Services |
Michael Policar, MD, MPH |
Cancer/Oncology |
|
|
|
Enabling New Translational Discoveries Using a Genomic Data-Driven Nosology |
Atul Butte, MD, PhD |
Cancer/Oncology, Immunology |
|
|
|
UCSF / Northrop Grumman - Oncology Models Forum |
Atul Butte, MD, PhD |
Cancer/Oncology |
|
|
|
A Technological Platform for the Identification of Serine Proteases in Cancer |
Charles Craik, PhD |
Cancer/Oncology, Drug and Diagnostics Development |
|
|
|
Non-Invasive Differentiation of Benign Lesions from Aggressive Pancreatic Cancer |
Charles Craik, PhD |
Cancer/Oncology |
|
|
|
Extracellular Proteolysis as a Molecular Stratification Tool for Cancer |
Charles Craik, PhD |
Cancer/Oncology |
|
|
|
A Technological Platform for the Identification of Serine Proteases in Cancer |
Charles Craik, PhD |
Cancer/Oncology, Drug and Diagnostics Development |
|
|
|
CARAVAN: Checkpoint-Radiation-Vaccine Neoadjuvant Trial for Metastatic Prostate Cancer |
|
Cancer/Oncology |
|
|
|
Risk-Stratified Randomized Phase III Testing of Blinatumomab (IND#100135, NSC#765986) in First Relapse of Childhood B-Lymphoblastic Leukemia (B-ALL)" |
|
Cancer/Oncology |
|
|
|
A Phase 2 Study of Oral ENMD-2076 for the Treatment of Patients with Advanced Fibrolamellar Carcinoma (FLC) |
|
Cancer/Oncology |
|
|
|
Phase I Study of INC280 plus Erlotinib in Patients With C-Met Expressing Non-Small Cell Lung Cancer. |
|
Cancer/Oncology |
|
|
|
NCDs in India |
Reena Gupta, MD |
Noncommunicable and/or Chronic Disease, Cancer/Oncology, Cardiovascular Disease, Diabetes, Occupational and Environmental Disease, Diet, Exercise, and Obesity, Malnutrition, Micronutrients, Food Insecurity |
|
|
|
Phase III Global Study of MEDI4736 in Combination with Tremelimumab Therapy or MEDI4736 Monotherapy vs Standard of Care Platinum-Based Chemotherapy in First-Line Treatment of Patients with Locally Advanced or Metastatic Non Small-Cell Lung Cancer |
|
Cancer/Oncology, Pharmacology and Drug Treatment |
|
|
|
A Phase 1b Open-label Study to Evaluate the Safety and Tolerability of MEDI4736 in Combination with Tremelimumab in Subjects with Advanced Non-small Cell Lung Cancer |
|
Cancer/Oncology, Pharmacology and Drug Treatment |
|
|
|
A Phase 2 Proof-of-Concept Study of the Combination of ACP-196 and Pembrolizumab in Subjects with Advanced Non-small Cell Lung Carcinoma |
|
Cancer/Oncology, Pharmacology and Drug Treatment |
|
|
|
A Phase II, Multicenter Study of the EZH2 Inhibitor Tazemetostat in Adult Subjects with INI1-Negative Tumors or Relapsed/Refractory Synovial Sarcoma |
|
Cancer/Oncology |
|
|
|
A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Trial of Doxorubicin plus Olaratumab versus Doxorubicin plus Placebo in Patients with Advanced or Metastatic Soft Tissue Sarcoma |
|
Cancer/Oncology, Pharmacology and Drug Treatment |
|
|
|
A Phase 1b (Open-Label) / Phase 2 (Randomized, Double-Blinded) Study Evaluating Gemcitabine and Docetaxel with or without Olaratumab in the Treatment of Advanced Soft Tissue Sarcoma |
|
Cancer/Oncology, Drug and Diagnostics Development |
|
|
|
Prostate Cancer Foundation Young Investigator Award |
|
Cancer/Oncology, Residencies, Fellowships, and Postdoctoral Training |
|
|
|
Metastatic escape mechanisms in TKI resistant lung cancer |
|
Cancer/Oncology |
|
|
|
Risk-Benefit Trade-Offs for Whole Genome Sequencing |
Kathryn Phillips, PhD |
Cancer/Oncology, Genetics |
|
|
|
Coverage, Price, and Reimbursement for Multigene Tests for Cancer and Related Conditions |
Kathryn Phillips, PhD |
Cancer/Oncology, Genetics |
|
|
|
Treatment Decision Making Involvement in Adolescents and Young Adults With Cancer |
|
Cancer/Oncology, Adolescent Health |
|
|
|
A Novel Targeted Therapy for Medulloblastoma |
Jeremy Reiter, MD, PhD |
Cancer/Oncology |
|
|
|
Influencing cervical cancer prevention and detection online through social media |
Urmimala Sarkar, MD |
Cancer/Oncology, Women's Health |
|
|
|
Improving Survivorship Care for Diverse Cancer Patients Cared for in Safety-net Settings |
Urmimala Sarkar, MD |
Cancer/Oncology, Implementation and Behavioral Science |
|
|
|
Randomized Trial to Increase Adherence to Cervical Cancer Screening Guidelines for Young Women (UCSF sub-in) |
|
Cancer/Oncology, Women's Health |
|
|
|
PRE-VIEW An Interactive Video Doctor to Encourage Cancer Screening |
|
Cancer/Oncology, Access or Barriers to Care, Patient and Peer Education |
|
|
|
International Society of Pediatric Oncology (SIOP) Pediatric Oncology in Developing Countries(PODC) |
Linda Abramovitz, RN, MS |
Cancer/Oncology |
|
|
|
Twinning Black Lion Hospital in Addis Ababa, Ethiopia |
Linda Abramovitz, RN, MS |
Cancer/Oncology, Pediatrics, Training International Scholars and Clinicians |
|
|
|
Head and neck cancers in LMIC |
Rahul Seth, MD |
Cancer/Oncology, Surgery and Anesthesia |
|
|
|
Identification of the SNPs and their Interaction with environmental factors in Esophageal Cancer in Tanzania |
Li Zhang, PhD |
Cancer/Oncology, Occupational and Environmental Disease |
|
|
|
Breast Cancer Screening and Outcomes in Diverse Populations: Role of Comorbidity |
|
Cancer/Oncology, Women's Health |
|
|
|
Developing an breast FNA biopsy service in Trujillo Peru |
Ronald Balassanian, MD |
Cancer/Oncology, Drug and Diagnostics Development, Women's Health |
|
|
|
Cervical cancer screening among HIV positive Kenyan women |
|
Cancer/Oncology, Women's Health |
|
|
|
Breast cancer risk assessment, screening and prevention |
Jeffrey Tice, MD |
Cancer/Oncology, Women's Health |
|
|
|
Test characteristics of nipple aspirate fluid cytology for the prediction of breast cancer |
Jeffrey Tice, MD |
Cancer/Oncology, Women's Health |
|
|
|
Pediatric Kaposi Sarcoma, Botswana 2012 HIV Clinical Management Guidelines |
Anu Agrawal, MD |
HIV/AIDS, Cancer/Oncology, Pediatrics |
|
|
|
Kaposi Sarcoma Subgroup of WHO Guidelines Development Group for HIV-Associated Skin and Oral Conditions |
Anu Agrawal, MD |
HIV/AIDS, Cancer/Oncology, Pediatrics |
|
|
|
Long distance mentoring in global oncology |
Anu Agrawal, MD |
HIV/AIDS, Cancer/Oncology |
|
|
|
Texas Children’s Hospital Global Health Service Corps |
Anu Agrawal, MD |
Cancer/Oncology, Pediatrics |
|
|
|
Pilot Testing, Refinement, and Validation of the Infrastructure to Develop -RADS-based Registries |
Marc Kohli, MD |
Cancer/Oncology, Drug and Diagnostics Development |
|
|
|
Surgical and cancer screening capacity building |
Loie Sauer, MD |
Surgery and Anesthesia, Cancer/Oncology, Health Systems Strengthening, Training and Capacity Building |
|
|
|
Management of esophageal cancer in East Africa: a prospective cohort study of treatment strategies and supportive care |
Geoffrey Buckle, MD, MPH |
Noncommunicable and/or Chronic Disease, Cancer/Oncology |
|
|
|
Radiation Oncology Solutions in Tanzania |
Owen Kenton, MS |
Cancer/Oncology |
|
|
|
Validation of the GeneXpert Breast Cancer STRAT4 Assay for Rapid Analysis of Breast Cancer Biomarker Status from Fine Needle Aspiration Biopsies in Tanzania (GX-BCB |
Dianna Ng, MD |
Cancer/Oncology, Drug and Diagnostics Development, Women's Health |
|
|
|
Evaluation of Colorectal Cancer Clinical Decision-Making and Outcomes at a National Cancer Referral Center in Dar es Salaam, Tanzania |
Alex Keir, MS |
Cancer/Oncology |
|
|
|
Implementation of Tanzania’s Cancer Treatment Guidelines: A Qualitative Health Systems Approach |
Rohan Luhar, MS |
Cancer/Oncology, Systematic Reviews and Guideline Development |
|
|
|
Pediatric capacity building |
Lena Winestone, MD, MSHP |
Cancer/Oncology, Pediatrics |
|
|
|
Racial and Ethnic Disparities in Pediatric Leukemia |
Lena Winestone, MD, MSHP |
Cancer/Oncology, Pediatrics |
|
|
|
Integration of wound and lymphedema care within a population health model in Western Kenya |
Aileen Y. Chang, MD |
Cancer/Oncology, Training and Capacity Building |
|
|
|
An Ethical Approach to Routine Tragic Choices: Radiotherapy Allocation in Rwanda |
Rebecca J. Deboer, MD |
Cancer/Oncology |
|
|
|
Implementation of Guideline-Based Clinical Practice at Ocean Road Cancer Center in Tanzania |
Rebecca J. Deboer, MD |
Cancer/Oncology, Policy and Standards of Care |
|
|
|
Sleep and Cancer: Evaluation of Risk and Insights into Mechanisms |
Peggy J. Reynolds, PhD, MPH, MA |
Cancer/Oncology, Occupational and Environmental Disease |
|
|
|
Occupational Chemical Exposures in California and Breast Cancer |
Peggy J. Reynolds, PhD, MPH, MA |
Cancer/Oncology, Occupational and Environmental Disease, Women's Health |
|
|
|
A study of environmental exposure to perfluorinated substances and cancer risk in California |
Peggy J. Reynolds, PhD, MPH, MA |
Cancer/Oncology, Occupational and Environmental Disease |
|
|
|
Innovative Infrastructure to Enhance the California Teachers Study |
Peggy J. Reynolds, PhD, MPH, MA |
Cancer/Oncology, Occupational and Environmental Disease |
|
|
|
Association Between Long-Term Ultrafine Particulate Matter Exposure and Premature Death |
Peggy J. Reynolds, PhD, MPH, MA |
Cancer/Oncology, Occupational and Environmental Disease |
|
|
|
Menopausal Transition - A Window of Susceptibility for the Promotion of Breast Cancer by Environmental Exposures |
Peggy J. Reynolds, PhD, MPH, MA |
Cancer/Oncology, Occupational and Environmental Disease, Women's Health |
|
|
|
Feasibility and acceptability of the Enhanced Visual Assessment (EVA) mobile colposcope for cervical cancer screening among HIV-infected women in low-resource settings |
Chemtai Mungo, MD, MPH |
Cancer/Oncology, Women's Health |
|
|
|
Cervical cancer in sub-Saharan Africa |
Chemtai Mungo, MD, MPH |
Cancer/Oncology, Women's Health |
|
|
|
Implementing digital technology to accelerate radiotherapy delivery for cervical cancer in Tanzania |
Melody Xu, MD |
Cancer/Oncology, Women's Health, Distance learning and mentoring |
|
|
|
Bundling postpartum cervical cancer screening with early childhood vaccinations in Kampala, Uganda |
Megan Swanson, MD, MPH |
Cancer/Oncology, Women's Health, Access or Barriers to Care |
|
|
|
Early Life Factors (Before Age 18) and Breast Cancer Risk in Asian-American Women |
Harry Lin, MS |
Infectious Disease, Cancer/Oncology, Adolescent Health |
|
|
|
Examining the Impact of Life Experiences on Patients' Satisfaction with Prostate Cancer Treatment Among Black Males |
Diamond Coleman, MS |
Cancer/Oncology |
|
|